World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 5th Edition, The

Keywords : Enteral nutrition

This Kalorama Information report - The World Market for Clinical Nutrition Products - focuses on three primary segments of essential medical nutrition: Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort) Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients) Parenteral Nu...

More »

This Kalorama Information report - The World Market for Clinical Nutrition Products - focuses on three primary segments of essential medical nutrition:

• Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort)


• Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients)


• Parenteral Nutrition

For each category, the report provides revenue data and forecasts for the most important segmentations. The report includes incidence of conditions which often require enteral or parenteral feeding, birth rates, over 65 population, and overall global population. Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, and other key markets. The market segments provide an overview, description of products on the market, new developments, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.






There are several issues and trends that are impacting the clinical nutrition market, including:

• Wound Care Applications


• Reimbursement of Nutrition Products


• Food Programs Adjusted Numbers for Recession


• Disease Statistics


• Nursing Home and Hospice Trends


• Nutrition and Education


• DHA and ANA Additives


• Counterfeit Infant Formulas


• Infant Formula Recalls


• Acquisition, Mergers and Alliances


• Enteral Feeding Pumps

A Growing Market with Thriving Competition

Competition in the clinical nutrition market is dominated by a handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies. The majority of competitive participation is in developed regions such as the United States, Western Europe, and Japan. However, many companies are expanding into less developed regions, intensifying competition in less tapped markets. China, for example, is among the expanding competitive regions as companies continue to break into the growing demand for clinical nutrition in new world markets. Companies highlighted in this study include:

• Abbott


• Baxter


• B Braun


• Danone


• Fresenius Kabi


• Hospira


• Mead Johnson


• Nestle


• Perrigo Company


• Pfizer

Revenues for each segment were generated using dollar and unit sales for each product.



The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 70 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with nutrition company representatives included marketing directors, division managers, and product representatives.



All market data pertains to the world market at the manufacturers’ level. The base year for data was 2011. Historical data was provided for the years 2006 through 2011, with forecast data provided for 2012 through 2016. Compound annual growth rates (CAGRs) are provided for the 2006-2011, 2010-2016 and 2006-2016 periods for each industry segment covered. Competitive analysis is provided for the year 2011. The forecasted market analysis for 2011-2016 was based on demographic trends, new developments, and global expansion.

Global Drug Delivery Technology Industry

CHAPTER ONE: EXECUTIVE SUMMARY

Introduction

Infant Nutrition

Enteral Nutrition

Parenteral Nutrition

Scope and Methodology

Size and Growth of the Market

Issues and Trends Affecting the Market

Leading Competitors

CHAPTER TWO: INTRODUCTION TO THE CLINICAL NUTRITION INDUSTRY

Introduction and History of Nutrition in the Clinical Setting

Defining Clinical Nutrition

Infant Nutrition

Enteral Nutrition

Parenteral Nutrition

Regulatory Environment

Environments for Clinical Nutrition

Hospital Settings

United States

International

Skilled Nursing Settings

United States

International

Home Care Settings

Hospice

Essential Nutrients

Carbohydrates

Proteins

Fats

Vitamins

Minerals

Demographics and Statistics

Worldwide Demographics

Global Aging Population

U.S. Demographics

U.S. Aging Population

Cancer and Nutrition

Cardiovascular Disease and Nutrition

Diabetes and Nutrition

HIV/AIDS and Nutrition

Obesity and Nutrition

Summary of Diseases

CHAPTER THREE: INFANT NUTRITION

Overview

Product Categories

Milk-based Formulas

Soy-based Formulas

Elemental Formulas

Follow-Up Formulas

Organic Infant Formula

Probiotic/Prebiotic Infant Formula

Premature Infant Formulas

Newborn Formulas

Other Specialized Formulas

Research & Development Trends

Market Size and Growth

Global Market Introduction

Sales by Product Type

Global Markets

Competitive Analysis

CHAPTER FOUR: ENTERAL NUTRITION

Overview

Product Categories

Industry Developments

Current Developments

Recent Business Activities

New Product Launches

Market Size and Growth

Global Market Introduction

Sales by Product Type

Global Markets

Competitive Analysis

CHAPTER FIVE: PARENTERAL NUTRITION

Overview

Product Categories

Amino Acids

Dextrose

Fats

Nutritional Additives

Industry Developments

Market Size and Growth

Global Market Introduction

Sales by Product Type

Global Markets

Competitive Analysis

CHAPTER SIX: TOTAL MARKET SIZE AND FORECAST

Total Market Size and Forecast

Global Market Overview

Sales by Broad Market Segment

Markets by Geographic Region

Competitor Analysis

CHAPTER SEVEN: ISSUES AND TRENDS AFFECTING

THE NUTRITION MARKET

Introduction

Wound Care applications

Parenteral Nutrition Shortages

Infant Formulas or Breast Milk: A Controversial Topic

Breast Feeding Rates in the U.S.

WHO

Manufacturer Marketing of Infant Formula

Reimbursement of Nutrition Products

Food Programs

WIC

WIC Contracts

Other Programs for Infant Formula Reimbursement

Cost Containment

Nutrition and Education

The Registered Dietician

Dietician Statistics in the United States

DHA and ARA Additives

Counterfeit Infant Formulas

Recalls for Infant Formulas

Industry Acquisitions, Mergers and Alliances

Enteral Feeding Pumps

Abbott Laboratories

Caesarea Medical Electronics

Covidien/Kendall

Fresenius Kabi

Nestle Nutrition

Moog, Inc.

CHAPTER EIGHT: CORPORATE PROFILES

Introduction

Abbott

Baxter

B Braun

Danone

Fresenius Kabi

Hospira

Mead Johnson Nutrition

Nestlé

Perrigo

Pfizer

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1

The Global Market for Clinical Nutrition, 2008-2016

Figure 1-1

The Global Market for Clinical Nutrition 2008-2016

CHAPTER TWO: INTRODUCTION TO THE CLINICAL NUTRITION INDUSTRY

Table 2-1

Nutrient Requirements for Infant Formulas as Required by the FDA Infant Formula Act

Table 2-2

U.S. Registered Hospitals by Type, 2010

Figure 2-1

Number of Hospitals in the US, 1975-2005, Estimated 2015

Table 2-3

Statistics for U.S. Hospitals, 2010

Table 2-4

U.S. Hospital Length of Stay, Average by Age Group

Table 2-5

Registered Hospitals and Acute Care Centers by Country

Figure 2-2

Number of Nursing Homes, 2000-2010

Table 2-6

Estimated Nursing Service Establishments and Care Centers by Country

Figure 2-3

Number of Home Care Agencies in the U.S., 1980-2009

Figure 2-4

Growth in Hospice Programs in the United States, 1998-2009

Figure 2-5

Patients Served with Hospice Programs in the United States, 1998-2009

Table 2-7

Percentage of Hospice Admissions by Primary Diagnosis, 2005 -2009

Table 2-8

Hospice Cases by Diagnosis, 2010 Estimates

Table 2-9

Essential Nutrients for Human Health

Table 2-10

World Population by Selected Geographical Region, 2010 - 2050

Figure 2-6

World Population by Selected Geographical Region, 2010–2050

Table 2-11

Percent Population Over 65 by Year and Region, 2010-2050

Table 2-12

International Population Trend Age 65+

Figure 2-7

International Population Trend Age 65+

Figure 2-8

Estimated World Population by Age, 2010 and 2050

Table 2-13

The U.S. Population, 1980-2050

Figure 2-9

The U.S. Population, 1980-2050

Table 2-14

United States Population Trend Age 65+

Figure 2-10

United States Population Trend Age 65+

Table 2-15

World Cancer Incidence by Selected Types of Cancer, 2010 and 2020, all races, both sexes

Figure 2-11

Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2010 and 2020

Table 2-16

Total Cancer Incidence by Sex and Country, 2010 Estimates

Figure 2-12

Total Cancer Incidence by Sex and Country, 2010 Estimates

Table 2-17

Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Cancer

Table 2-18

Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Cardiovascular Diseases

Table 2-19

Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Type 2 Diabetes

Table 2-20

Total Number of People Living with HIV/AIDS, Newly Infected Population and Deaths, 2010 by Region

Figure 2-13

The Role of Nutrition Education as HIV Infection Develops

Table 2-21

Estimated Obesity by Country, 2009 Estimates

Figure 2-14

Estimated Obesity by Country as a Portion of Total Population 2009 Estimates

Figure 2-15

Increases in Obesity by Country—2007 and 2009 Figures

Table 2-22

Summary of Strength of Evidence on Factors that Might Promote or Protect Against Weight Gain and Obesity

Table 2-23

Classification of Overweight in Adults According to BMI

Table 2-24

Prevalence/Incidence of Diseases by Type, 2010 Estimates

Figure 2-16

Prevalence/Incidence of Disease by Type, 2010 Estimates

Figure 2-17

Prevalence/Incidence of Disease by Type, 2010 Estimates

Table 2-25

Disease Mortality by Type, 2010 Estimates

Figure 2-18

Disease Mortality by Type, 2010 Estimates

Figure 2-19

Disease Mortality by Type, 2010 Estimates

CHAPTER THREE: INFANT NUTRITION

Table 3-1

Composition of Breast Milk (early and mature range) and Select Infant Formulas

Table 3-2

Live Births and Birth Rates by Country*

Figure 3-1

Live Births by Country

Figure 3-2

Births Rates by Country

Figure 3-3

Children Under 5 Years

Table 3-3

Marketed Infant Formulas (Manufacturer, Product Types, and Product Lines)

Table 3-4

The Market for Infant Nutrition 2008-2016

Figure 3-4

The Global Market for Infant Nutrition 2008-2016

Table 3-5

The Global Market for Infant Nutrition by Product Type 2012

Figure 3-5

The Global Market for Infant Nutrition by Product Type 2012

Table 3-6

The Global Market for Infant Nutrition Estimated Products Sales by Select Geographic Region, 2012

Figure 3-6

The Global Market for Infant Nutrition Market Share by Select Geographic Region,2012

Table 3-7

The Global Market for Infant Nutrition Estimated Revenues and Market Share of Leading Suppliers, 2012

Figure 3-7

The Global Market for Infant Nutrition Estimated Market Share by Leading Suppliers 2012

Table 3-8

The Global Market for Infant Nutrition Estimated Market Shares by Region for Leading Suppliers 2012

Figure 3-8

Estimated Infant Formula U.S. Market Shares for Leading Suppliers 2012

Figure 3-9

Estimated Infant Formula Market Shares Outside the U.S. for Leading Suppliers 2012

CHAPTER FOUR: ENTERAL NUTRITION

Table 4-1

Aging Population, Percent of Total Population, and Annual Growth by Country, 2012

Figure 4-1

Over 65 Population by Country

Figure 4-2

Over 65 Population as a Percent of Total Population by Country, 2012

Figure 4-3

Over 65 Annual Population Growth by Country

Table 4-2

Marketed Pediatric and Adult Enteral Formulas (Manufacturer, Product Types, and Product Lines)

Table 4-3

The Market for Enteral Nutrition 2008-2016

Figure 4-4

The Global Market for Enteral Nutrition 2008-2016

Table 4-4

The Global Market for Enteral Nutrition by Product Type, 2012

Figure 4-5

The Global Market for Enteral Nutrition by Product Type, 2012

Table 4-5

The Global Market for Enteral Nutrition Estimated Products Sales by Select Geographic Region, 2012

Figure 4-6

The Global Market for Enteral Nutrition Market Share by Geographic Region, 2012

Table 4-6

The Global Market for Enteral Nutrition Estimated Revenues and Market Share of Leading Suppliers, 2012

Figure 4-7

The Global Market for Enteral Nutrition Estimated Market Share by Leading Suppliers,2012

Table 4-7

The Global Market for Enteral Nutrition Estimated Market Shares by Region for Leading Suppliers, 2012

Figure 4-8

The Global Market for Enteral Nutrition Estimated U.S. Market Shares for Leading Suppliers, 2012

Figure 4-9

The Global Market for Enteral Nutrition Estimated Market Shares Outside the U.S. for Leading Suppliers, 2012

CHAPTER FIVE: PARENTERAL NUTRITION

Table 5-1

Aging Population, Percent of Total Population, and Annual Growth by Country*, 2012

Figure 5-1

Over 65 Population by Country

Figure 5-2

Over 65 Population as a Percent of Total Population by Country, 2012

Figure 5-3

Over 65 Annual Population Growth by Country

Table 5-2

Standard Electrolyte Requirements

Table 5-3

Standard Parenteral Multivitamin Package* Vitamin

Table 5-4

Standard Parenteral Trace Elements Package

Table 5-5

Single Parenteral Trace Element Formulations

Table 5-6

Major Marketed Parenteral Formulas (Manufacturer, Product Types, and Product Lines)

Table 5-7

The Market for Parenteral Nutrition 2008-2016

Figure 5-4

The Global Market for Parenteral Nutrition 2008-2016

Table 5-8

The Global Market for Parenteral Nutrition by Product Type* 2012

Figure 5-5

The Global Market for Parenteral Nutrition by Product Type* 2012

Table 5-9

The Global Market for Parenteral Nutrition Estimated Products Sales by Select Geographic Region, 2012

Figure 5-6

The Global Market for Parenteral Nutrition Market Share by Select Geographic Region,2012

Table 5-10

The Global Market for Parenteral Nutrition Estimated Revenues and Market Share of Leading Suppliers 2012

Figure 5-7

The Global Market for Parenteral Nutrition Estimated Market Share by Leading Suppliers 2012

Table 5-11

The Global Market for Parenteral Nutrition Estimated Market Shares by Region for Leading Suppliers 2012

Figure 5-8

The Global Market for Parenteral Nutrition Estimated U.S. Market Shares for Leading Suppliers 2012

Figure 5-9

The Global Market for Parenteral Nutrition Estimated Market Shares Outside the U.S. for Leading Suppliers 2012

CHAPTER SIX: TOTAL MARKET SIZE AND FORECAST

Table 6-1

The Global Market for Clinical Nutrition 2008-2016

Figure 6-1

The Global Market for Clinical Nutrition 2008-2016

Table 6-2

The Global Market for Clinical Nutrition by Product Type 2008-2016

Figure 6-2

The Global Market for Clinical Nutrition by Type 2008-2016

Figure 6-3

The Global Market for Clinical Nutrition by Type 2012

Figure 6-4

The Global Market for Clinical Nutrition by Type 2016

Table 6-3

The Global Market for Clinical Nutrition by Country 2008, 2010 and 2012

Figure 6-5

The Global Market for Clinical Nutrition by Country 2008, 2010 and 2012

Table 6-4

Leading Suppliers Clinical Nutrition Revenues and Significant Segments of Participation, 2012

Figure 6-6

Leading Suppliers Clinical Nutrition Estimated Market Shares, 2012

CHAPTER SEVEN: ISSUES AND TRENDS AFFECTING THE NUTRITION MARKET

Table 7-1

Nutrition Products with Specific Wound Management Benefits

Table 7-2

Parenteral Nutrition Shortages, updated September 2012

Table 7-3

U.S. National Breastfeeding Statistics

Figure 7-1

U.S. National Breastfeeding Statistics

Table 7-4

Medicare Reimbursement for Home Parenteral and Enteral Nutrition; DME MAC.

Table 7-5

Enteral Product Classification, 2012

Table 7-6

Example of DMEPOS Fee Schedule for Common Enteral Items, 2012 Fee Schedule

Table 7-7

Example of DMEPOS Fee Schedule for Common Parenteral Items, 2012 Fee Schedule

Table 7-8

WIC Participants by Participant Category in 2006, 2009, 2010

Figure 7-2

Distribution of WIC Participants by Type, 2006

Figure 7-3

Distribution of WIC Participants by Type, 2010

Table 7-9

WIC Agencies and Distribution of Participants by State, 2010

Table 7-10

Dieticians and Nutritionists by Facility Type, 2011

Table 7-11

Highest Number of Dieticians and Nutritionists by State, 2011

Table 7-12

Highest Concentration of Dieticians and Nutritionists by State, 2011

Table 7-13

Recalls of Infant Feeding Products, 2001-2012

Table 7-14

Selected Enteral Feeding Pumps